Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
|Articles|March 1, 2003
- Volume 0 0
March 2003: Rx Image One
Advertisement
A patient dropped off this Rx at the counter and left before pharmacy technician Charlene Waldron and pharmacist M. Chantz Eyring of Walgreens Pharmacy #2708 in Farmington, NM, could ask what medication was prescribed. After reviewing the patient profile and finding several other prescriptions for a similar medication written by the same prescriber, they figured it out. During counseling, the patient confirmed their choice. What would your answer be?
Click Here For The Answer ----------->
[
Famvir 125 mg, 1 bid, #10, 2 refills
toggle(getObject('exp1048685570_link'), 'exp1048685570');
Articles in this issue
over 23 years ago
Compounding a hydroxyurea liquidover 23 years ago
Does "HC" mean "hydrophilic cream"?over 23 years ago
A Vision for Pharmacy and How to Get There?Part 1over 23 years ago
Humira (adalimumab, D2E7)over 23 years ago
Drug Diversion Versus Pain Management?Part 1over 23 years ago
Pharmacy Pays Dearly After Misleading Courtover 23 years ago
Becoming a Culturally Competent Pharmacistover 23 years ago
Is There a Vaccine in Your Future?over 23 years ago
Growing Professionally with a MentorNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
What Different Communities Taught Me About Patient Care
3
Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC
4
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
5